February 6, 2012
With a fresh new year ahead of us, we want to recap on some of
the most important events of last year, as well as share with you
our ambitions for the year to come.
2011 - a year to remember
2011 was in many ways a landmark in the Uniferon history marked
among other things by our launch on the US market with the approval
of the FDA in July. A truly important stepping-stone in our global
Uniferon endeavors.
2011 was also the year where we could welcome a large group of
new Partners to the Uniferon "family", including Germany, Holland,
Spain, Portugal, Serbia, Russia, Denmark, Norway, Iceland, Sweden
and Finland. It is great feeling knowing that we have a competent
and dedicated group of Partners worldwide joining the efforts in
making Uniferon the no. 1 iron supplementation in the world.
The preceding year saw many new initiatives that we are
genuinely proud of, not least the Iron Weight/Gain Optimizer, which is found
right here on uniferon.com. If you have not yet tried the online
simulator, we encourage you to have a go and learn for yourself how
this exciting tool can provide a deeper understanding of the
relationship between iron and growth.
2012 - an exciting year to come
Our visions for 2012 are clear. We want to continue our efforts
in making Uniferon available for pig farmers and continue making
Uniferon the easy and clever choice for clever breeders. There are
exciting challenges ahead of us and we are bursting with motivation
to continue our work with quality iron supplementation.
In 2012 Pharmacosmos and Uniferon will be present at both the
IPVS and the AASV in March, where we will address issues of
importance to representatives from the American pig industry. And
we look forward to seeing many of you out there "in the real world"
in 2012.
About Uniferon
Uniferon is a modern improved iron hydrogenated dextran based on
a natural formula, which is approved for global use:
Uniferon is manufactured without the use of any organic solvents
or cyanide, thus, avoiding trace residues of these impurities.
Pharmacosmos manufactures iron dextran of high quality and unique
purity for customers worldwide. Uniferon is the only injectable
iron brand for piglets approved in the EU, the US and Asia.
About Pharmacosmos
Headquartered in Denmark, Pharmacosmos is a family-owned,
international healthcare company with more than 50 years of
innovation and leadership in iron- and carbohydrate-based
treatments and solutions for human and animal use.
A research-based company, its ongoing R&D programme focuses
on improving the lives of patients with iron deficiency with or
without anaemia. More than 1 billion people live with iron
deficiency anaemia and it is the leading cause of death for an
estimated 180,000 people every year. This makes it one of the
largest global health challenges of our time.
Pharmacosmos has subsidiaries in the Nordics, the UK and the US
and its products are marketed in more than 80 countries across the
world. Its manufacturing facilities are approved, among others, by
the Danish Medicines Agency and the US FDA.